What makes the I-neb AAD System unique?
A. The I-neb AAD System uses Adaptive Aerosol Delivery (AAD) technology to precisely and reproducibly deliver Ventavis to every patient, at either dose (2.5 mcg or 5.0 mcg), using a single ampule of medication. The I-neb AAD System monitors a patient’s unique breathing pattern and continually adapts to breathing changes during treatment to deliver a precise dose. The I-neb AAD System delivers aerosolized Ventavis during the first 80% of inhalation, ensuring no medication is wasted in the deadspace on inhalation or lost to the environment on exhalation. With the I-neb AAD System, a medication chamber controls the dose and a control disc operates the I-neb AAD System. Once a patient receives a complete dose, the I-neb AAD System stops delivering aerosol and signals the user with visual and audible indicators.